Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo FILE PHOTO: The Eli Lilly logo is shown on one ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

Eli Lilly (NYSE:LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in the country. According to the agreement announced by the companies, Lilly ...

Novo Nordisk (NVO) and Eli Lilly & Co. (LLY) shares are trending lower in pre-market trading after President Donald Trump said the price of Ozempic, Novo’s top-selling weight-loss and diabetes drug, ...

COPENHAGEN (Reuters) -Shares of weight-loss drug makers Novo Nordisk and Eli Lilly fell on Friday after U.S. President Donald Trump said that the price of Novo's popular Ozempic treatment would be ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

Pharma giant Eli Lilly tapped Walmart to offer in-store pickups of Zepbound vials, marking the first retail collaboration for its direct-to-consumer platform LillyDirect. Walmart, which operates ...

Eli Lilly has sued two compounding pharmacies for allegedly producing replicas of its diabetes and weight loss drugs. Eli Lilly has sued companies in 34 states on similar claims, alleging they ...

FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly's experimental ...

Eli Lilly said its investigational oral GLP-1 weight-loss drug, orforglipron, met its primary endpoints in two recent phase 3 trials. The medicine company said Wednesday the drug met the primary and ...

Shares of Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are moving lower in Thursday’s after-hours session after President Donald Trump indicated that weight-loss drugs are going to come ...